These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8867868)

  • 1. Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study.
    Paulsen JS; Caligiuri MP; Palmer B; McAdams LA; Jeste DV
    Psychopharmacology (Berl); 1996 Feb; 123(4):307-14. PubMed ID: 8867868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.
    Jeste DV; Caligiuri MP; Paulsen JS; Heaton RK; Lacro JP; Harris MJ; Bailey A; Fell RL; McAdams LA
    Arch Gen Psychiatry; 1995 Sep; 52(9):756-65. PubMed ID: 7654127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
    Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
    Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
    Morgenstern H; Glazer WM
    Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for severe tardive dyskinesia in older patients.
    Caligiuri MP; Lacro JP; Rockwell E; McAdams LA; Jeste DV
    Br J Psychiatry; 1997 Aug; 171():148-53. PubMed ID: 9337951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early course of new-onset tardive dyskinesia in older patients.
    Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV
    Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM; Woerner M; Lieberman J
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):52S-56S. PubMed ID: 3065365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tardive dyskinesia: a review].
    Crespo Facorro B; Payá González B; Ruiz Fernández V; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):118-27. PubMed ID: 9245189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
    Glazer WM; Morgenstern H; Doucette JT
    J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between ECT responsiveness and subtypes of tardive dyskinesia in bipolar patients.
    Sandyk R
    Int J Neurosci; 1990 Oct; 54(3-4):315-9. PubMed ID: 2265982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
    Bailey LG; Maxwell S; Brandabur MM
    Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of tardive dyskinesia. A multivariate analysis.
    Glazer WM; Morgenstern H; Niedzwiecki D; Hughes J
    Br J Psychiatry; 1988 Feb; 152():253-9. PubMed ID: 3262396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia.
    Levchenko A; Kanapin A; Samsonova A; Fedorenko OY; Kornetova EG; Nurgaliev T; Mazo GE; Semke AV; Kibitov AO; Bokhan NA; Gainetdinov RR; Ivanova SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110134. PubMed ID: 33065217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.
    Sachdev P
    Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.
    Lerer B; Segman RH; Tan EC; Basile VS; Cavallaro R; Aschauer HN; Strous R; Chong SA; Heresco-Levy U; Verga M; Scharfetter J; Meltzer HY; Kennedy JL; Macciardi F
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):411-25. PubMed ID: 15857569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of tardive dyskinesia incidence in the elderly.
    Saltz BL; Woerner MG; Kane JM; Lieberman JA; Alvir JM; Bergmann KJ; Blank K; Koblenzer J; Kahaner K
    JAMA; 1991 Nov; 266(17):2402-6. PubMed ID: 1681122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases.
    Chouinard G; Annable L; Ross-Chouinard A; Mercier P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):21S-26S. PubMed ID: 3220967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.